$ARIA Company News Six stocks to watch 4:27 p.
Post# of 94146
Posted On: 04/11/2014 11:46:51 AM
$ARIA Company News
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
Causeway Capital's Sarah Ketterer Responds to GuruFocus Reader Questions 4:33 p.m. April 4, 2014 - GuruFocus.com
Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte Shares Drop 11:23 a.m. March 28, 2014 - benzinga.com
Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte Shares Drop 11:23 a.m. March 28, 2014 - benzinga.com
Mid-Morning Market Update: Markets Open Higher; BlackBerry Reports Smaller-Than-Expected Loss 9:22 a.m. March 28, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – MNKD ARIA CYH HALO 9:00 a.m. March 28, 2014 - InvestorPlace.com
Aria up premarket on buyout rumors 7:35 a.m. March 28, 2014 - Seeking Alpha
ARIA Stock Gets Big Boost From JAZZ Buyout Rumors 7:20 a.m. March 28, 2014 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. March 28, 2014 - benzinga.com
Novartis lung-cancer drug produces response in over half of patients 4:26 a.m. March 27, 2014 - Seeking Alpha
ARIAD Candidate in Phase II Study - Analyst Blog 6:10 p.m. March 26, 2014 - Zacks.com
Novartis Drug Shows Promise in Rare Lung Cancer 5:20 p.m. March 26, 2014 - The Wall Street Journal Interactive Edition
Novartis Targeted Lung Cancer Drug Highlighted in This Week's NEJM 5:14 p.m. March 26, 2014 - TheStreet.com
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead 8:12 a.m. March 26, 2014 - Seeking Alpha
Cramer's Mad Money - The 'What, Me Worry?' HMOs (3/25/14) 6:22 a.m. March 26, 2014 - Seeking Alpha
Morning Market Movers 8:39 a.m. March 25, 2014 - benzinga.com
Why Now Is The Time To Buy Ariad Pharmaceuticals 3:20 p.m. March 24, 2014 - Seeking Alpha
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
Cramer's Mad Money - Which IPOs To Watch, Which IPOs To Ignore (3/17/14) 6:15 a.m. March 18, 2014 - Seeking Alpha
Perilous Reversal Watch: Ariad Pharmaceuticals (ARIA) 3:03 p.m. March 17, 2014 - TheStreet.com
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog 10:58 a.m. March 5, 2014 - Zacks.com
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. Today - PR Newswire - PRF
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird 1:00 a.m. April 8, 2014 - ACCESSWIRE
Apollo Education Sinks on Disappointing Earnings; Rubicon Project Makes Grand Debut on NYSE 12:12 a.m. April 3, 2014 - ACCESSWIRE
Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Community Health, and United Technologies 8:00 a.m. April 2, 2014 - PR Newswire - PRF
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer 7:35 a.m. April 2, 2014 - BusinessWire - BZX
Technical Pointers on Top Gainers -- Research on ARIAD Pharma, Arotech, Restoration Hardware Holdings, and Sprouts Farmers Market 12:52 p.m. March 31, 2014 - PR Newswire - PRF
Newmont Mining Corp Denies Cutting Output; Indonesian Copper and Gold Mine and Ford Raised CEO Alan Mulally's Compensation by 11% 12:16 a.m. March 31, 2014 - ACCESSWIRE
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer 7:35 a.m. March 24, 2014 - BusinessWire - BZX
Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes on ARIAD, NewLink, Puma Biotechnology, Theravance, and Ohr Pharmaceutical 8:00 a.m. March 12, 2014 - PR Newswire - PRF
Most Active Equities Technical Snapshot: SandRidge Energy, Ariad Pharma, Groupon, and Vodafone 10:12 a.m. March 11, 2014 - PR Newswire - PRF
New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara 7:24 a.m. March 5, 2014 - PR Newswire - PRF
Workday Upgraded to $150 a Share; Ariad Pharmaceuticals Q4 Loss Widens 12:34 a.m. Feb. 28, 2014 - ACCESSWIRE
ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014 7:35 a.m. Feb. 25, 2014 - BusinessWire - BZX
ARIAD to Present at the Cowen and Company 34th Annual Health Care Conference 7:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
ARIAD Expands Its Board of Directors with Appointment of Alexander J. Denner, Ph.D. of Sarissa Capital Management 7:35 a.m. Feb. 21, 2014 - BusinessWire - BZX
Facebook to Buy Messaging App WhatsApp; Garmin Ltd. Hits New 1-year High on Earnings 12:29 a.m. Feb. 20, 2014 - ACCESSWIRE
ARIAD to Present at the RBC Capital Markets Healthcare Conference 7:35 a.m. Feb. 19, 2014 - BusinessWire - BZX
ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014 7:35 a.m. Feb. 10, 2014 - BusinessWire - BZX
TrendingWallStreet.com Announces Coverage on DDD, ARIA, ENIP, and LATF 12:24 a.m. Feb. 6, 2014 - ACCESSWIRE
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
Causeway Capital's Sarah Ketterer Responds to GuruFocus Reader Questions 4:33 p.m. April 4, 2014 - GuruFocus.com
Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte Shares Drop 11:23 a.m. March 28, 2014 - benzinga.com
Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte Shares Drop 11:23 a.m. March 28, 2014 - benzinga.com
Mid-Morning Market Update: Markets Open Higher; BlackBerry Reports Smaller-Than-Expected Loss 9:22 a.m. March 28, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – MNKD ARIA CYH HALO 9:00 a.m. March 28, 2014 - InvestorPlace.com
Aria up premarket on buyout rumors 7:35 a.m. March 28, 2014 - Seeking Alpha
ARIA Stock Gets Big Boost From JAZZ Buyout Rumors 7:20 a.m. March 28, 2014 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. March 28, 2014 - benzinga.com
Novartis lung-cancer drug produces response in over half of patients 4:26 a.m. March 27, 2014 - Seeking Alpha
ARIAD Candidate in Phase II Study - Analyst Blog 6:10 p.m. March 26, 2014 - Zacks.com
Novartis Drug Shows Promise in Rare Lung Cancer 5:20 p.m. March 26, 2014 - The Wall Street Journal Interactive Edition
Novartis Targeted Lung Cancer Drug Highlighted in This Week's NEJM 5:14 p.m. March 26, 2014 - TheStreet.com
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead 8:12 a.m. March 26, 2014 - Seeking Alpha
Cramer's Mad Money - The 'What, Me Worry?' HMOs (3/25/14) 6:22 a.m. March 26, 2014 - Seeking Alpha
Morning Market Movers 8:39 a.m. March 25, 2014 - benzinga.com
Why Now Is The Time To Buy Ariad Pharmaceuticals 3:20 p.m. March 24, 2014 - Seeking Alpha
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
Cramer's Mad Money - Which IPOs To Watch, Which IPOs To Ignore (3/17/14) 6:15 a.m. March 18, 2014 - Seeking Alpha
Perilous Reversal Watch: Ariad Pharmaceuticals (ARIA) 3:03 p.m. March 17, 2014 - TheStreet.com
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog 10:58 a.m. March 5, 2014 - Zacks.com
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. Today - PR Newswire - PRF
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird 1:00 a.m. April 8, 2014 - ACCESSWIRE
Apollo Education Sinks on Disappointing Earnings; Rubicon Project Makes Grand Debut on NYSE 12:12 a.m. April 3, 2014 - ACCESSWIRE
Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Community Health, and United Technologies 8:00 a.m. April 2, 2014 - PR Newswire - PRF
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer 7:35 a.m. April 2, 2014 - BusinessWire - BZX
Technical Pointers on Top Gainers -- Research on ARIAD Pharma, Arotech, Restoration Hardware Holdings, and Sprouts Farmers Market 12:52 p.m. March 31, 2014 - PR Newswire - PRF
Newmont Mining Corp Denies Cutting Output; Indonesian Copper and Gold Mine and Ford Raised CEO Alan Mulally's Compensation by 11% 12:16 a.m. March 31, 2014 - ACCESSWIRE
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer 7:35 a.m. March 24, 2014 - BusinessWire - BZX
Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes on ARIAD, NewLink, Puma Biotechnology, Theravance, and Ohr Pharmaceutical 8:00 a.m. March 12, 2014 - PR Newswire - PRF
Most Active Equities Technical Snapshot: SandRidge Energy, Ariad Pharma, Groupon, and Vodafone 10:12 a.m. March 11, 2014 - PR Newswire - PRF
New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara 7:24 a.m. March 5, 2014 - PR Newswire - PRF
Workday Upgraded to $150 a Share; Ariad Pharmaceuticals Q4 Loss Widens 12:34 a.m. Feb. 28, 2014 - ACCESSWIRE
ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014 7:35 a.m. Feb. 25, 2014 - BusinessWire - BZX
ARIAD to Present at the Cowen and Company 34th Annual Health Care Conference 7:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
ARIAD Expands Its Board of Directors with Appointment of Alexander J. Denner, Ph.D. of Sarissa Capital Management 7:35 a.m. Feb. 21, 2014 - BusinessWire - BZX
Facebook to Buy Messaging App WhatsApp; Garmin Ltd. Hits New 1-year High on Earnings 12:29 a.m. Feb. 20, 2014 - ACCESSWIRE
ARIAD to Present at the RBC Capital Markets Healthcare Conference 7:35 a.m. Feb. 19, 2014 - BusinessWire - BZX
ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014 7:35 a.m. Feb. 10, 2014 - BusinessWire - BZX
TrendingWallStreet.com Announces Coverage on DDD, ARIA, ENIP, and LATF 12:24 a.m. Feb. 6, 2014 - ACCESSWIRE
(0)
(0)Scroll down for more posts ▼